𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cardiovascular disease risk in rheumatoid arthritis: Progress, debate, and opportunity

✍ Scribed by Henry R. Kramer; Jon T. Giles

Publisher
Wiley (John Wiley & Sons)
Year
2011
Tongue
English
Weight
137 KB
Volume
63
Category
Article
ISSN
2151-464X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cardiovascular risk factors in women wit
Cardiovascular risk factors in women with and without rheumatoid arthritis
✍ Daniel H. Solomon; Gary C. Curhan; Eric B. Rimm; Carolyn C. Cannuscio; Elizabeth πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 64 KB πŸ‘ 2 views

## Abstract ## Objective The risk of cardiovascular disease (CVD) is increased in patients with rheumatoid arthritis (RA). The objective of this study was to examine the distribution of known CVD risk factors and biomarkers of CVD in women with and without RA. ## Methods This study included two

Leflunomide use and the risk of intersti
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis
✍ Samy Suissa; Marie Hudson; Pierre Ernst πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 2 views

## Abstract ## Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) treated with leflunomide, a disease‐modifying antirheumatic drug (DMARD), have been appearing recently. To assess this risk, we conducted a population‐based epidemiologic stud

High ten-year risk of cardiovascular dis
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study
✍ Hilal Maradit Kremers; Cynthia S. Crowson; Terry M. Therneau; Veronique L. Roger πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Abstract ## Objective To estimate the 10‐year absolute risk of cardiovascular (CV) events in newly diagnosed rheumatoid arthritis (RA) patients and the potential contribution of CV risk factors to absolute risk assessment. ## Methods A population‐based incidence cohort of RA patients (defined